Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis-Reference-Cited by-同舟云学术

Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis

Published:2014-08-25 Issue:7 Volume:193 Page:3278-3287
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Works Melissa G.,Yin Fangfang,Yin Catherine C.,Yiu Ying,Shew Kenneth,Tran Thanh-Thuy,Dunlap Nahoko,Lam Jennifer,Mitchell Tim,Reader John,Stein Paul L.,D’Andrea Annalisa

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Psoriasis: what we have learned from mouse models

2. Ustekinumab

3. Hiding under the skin: Interleukin-17–producing γδ T cells go under the skin?

4. A role for T cell-derived interleukin 22 in psoriatic skin inflammation

5. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yinxie I Formula attenuates imiquimod-induced psoriasis-like skin inflammation via IL-23/IL-17 axis;Archives of Dermatological Research;2024-08-19

2. CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models;Immunopharmacology and Immunotoxicology;2024-07-03

3. Multiplicative Effects of Essential Oils and Other Active Components on Skin Tissue and Skin Cancers;International Journal of Molecular Sciences;2024-05-15

4. Microbiome Modulation Uncouples Efficacy and Toxicity Induced by Programmed Death-1/Programmed Death-Ligand1 Blockade;2024-05-10

5. IL-22, a vital cytokine in autoimmune diseases;Clinical and Experimental Immunology;2024-04-23